SCHEMBL24915580

SCHEMBL24915580

CCOC(=O)c1ccn(C2COC2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.43
KDM4E B2RXH2 5/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
POLB P06746 1/20 0.39
FAAH O00519 2/20 0.39
OGFRL1 Q5TC84 1/20 0.38
JMJD6 Q6NYC1 1/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
RXFP1 Q9HBX9 1/20 0.38
TP53 P04637 1/20 0.38
HSD17B10 Q99714 1/20 0.38
GAA P10253 2/20 0.37
CASP3 P42574 1/20 0.37
CASP7 P55210 1/20 0.37
CASP8 Q14790 1/20 0.37
TSHR P16473 1/20 0.37
KMT2A Q03164 1/20 0.37
PIK3CA P42336 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24915325 0.90 TNF (0.40) CYP1A2KDM4EALDH1A1HPGDPOLB
SCHEMBL16244534 0.87 CYP1A2 (0.46) CYP1A2KDM4EALDH1A1HPGDPOLB
SCHEMBL15754077 0.86 ACKR3 (0.42) CYP1A2KDM4EALDH1A1POLBFAAH
SCHEMBL22637340 0.84 CYP1A2 (0.44) CYP1A2KDM4EALDH1A1POLBFAAH
SCHEMBL24958742 0.84 KMT2A (0.43) KDM4EALDH1A1HPGDPOLBJMJD6
SCHEMBL20722095 0.83 CYP1A2 (0.43) CYP1A2KDM4EALDH1A1HPGDPOLB
SCHEMBL31389468 0.83 ALDH1A1 (0.46) CYP1A2ALDH1A1POLBFAAHOGFRL1
SCHEMBL20722078 0.83 CYP1A2 (0.43) CYP1A2KDM4EALDH1A1HPGDPOLB
SCHEMBL20046891 0.82 CYP1A2 (0.42) CYP1A2KDM4EPOLBFAAHJMJD6
SCHEMBL24915298 0.81 CYP1A2 (0.41) CYP1A2KDM4EALDH1A1HPGDPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230145793-A1 SUBSTITUTED PYRIMIDINE OR PYRIDINE AMINE DERIVATIVE, COMPOSITION THEREOF, AND MEDICAL USE THEREOF SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2023-05-11 US disclosed
US-20230145793-A1 SUBSTITUTED PYRIMIDINE OR PYRIDINE AMINE DERIVATIVE, COMPOSITION THEREOF, AND MEDICAL USE THEREOF SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2023-05-11 US disclosed
EP-4122927-A1 SUBSTITUTED PYRIMIDINE OR PYRIDINE AMINE DERIVATIVE, COMPOSITION THEREOF, AND MEDICAL USE THEREOF Shanghai Haiyan Pharmaceutical Technology Co., Ltd. (CN) 2023-01-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230145793-A1 SUBSTITUTED PYRIMIDINE OR PYRIDINE AMINE DERIVATIVE, COMPOSITION THEREOF, AND MEDICAL USE THEREOF ADORA2A, ADORA2B, ADORA3 CYP1A2 170/4885KDM4E 3858/4885ALDH1A1 616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.